Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen Fawell currently holds 62,000 shares of C4 Therapeutics, Inc. (CCCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Fawell has been a net neutral trader of CCCC stock. They have purchased $0 and sold $0 worth of shares.
Stephen Fawell's most recent insider trade was on Jun 24, 2026, when they sold 62,000 shares at $0.00 per share.
Stephen Fawell serves as Executive at C4 Therapeutics, Inc. (CCCC). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Stephen Fawell holds the position of Executive at C4 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Stephen Fawell has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Stephen Fawell was on Jun 24, 2026, when they purchased $0 worth of CCCC shares. This transaction involved 62,000 shares at N/A per share.
Stephen Fawell currently owns 62,000 shares of C4 Therapeutics, Inc. (CCCC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen Fawell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen Fawell has 2 Form 4 filings on record as an insider at C4 Therapeutics, Inc..
Set alerts for Stephen Fawell and 40,000+ other insiders.